Ghosh Anirvan 4
4 · Unity Biotechnology, Inc. · Filed Jan 23, 2025
Insider Transaction Report
Form 4
Ghosh Anirvan
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-22+450,000→ 450,000 totalExercise: $2.09Exp: 2035-01-21→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]The underlying shares vest and become exercisable pursuant to the following schedule: one third of the shares subject to the option vest on December 31, 2025 and the remaining shares subject to the option vest in 24 successive, equal monthly installments thereafter on each monthly anniversary of December 31, 2025 until fully vested on December 31, 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.